Ref. No. IVL 004/02/2020 26 February 2020 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of
Ended December 31, 2018 To The President The Stock Exchange of Thailand Management Discussion and Analysis Consolidated Financial Statements For Financial Year ended December 31, 2018 Overall Group
December 31, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For Year Ended December 31, 2019 Overall Group Performance Table 1
1 (Translation) MD. 045/2019 February 27, 2019 Re: Management Discussion and Analysis For the Year Ended December 31, 2018 To: President The Stock Exchange of Thailand Management Discussion and
1 (Translation) MD. 045/2019 27 February 27, 2019 Re: Management Discussion and Analysis For the Year Ended December 31, 2018 To: President The Stock Exchange of Thailand Management Discussion and
March 31, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For three months ended March 31, 2019 Overall Group Performance Table
June 30, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For six months ended June 30, 2019 Overall Group Performance Table 1
, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company
29 October 2019 At: ACC/HO 023/19 Re: Management Discussion and Analysis for the Quarter of 3/2019 To: President The Stock Exchange of Thailand In the third quarter of 2019, there were concern on the